Trimebutine CTB salt

CAS No. 1456509-46-8

Trimebutine CTB salt( —— )

Catalog No. M34266 CAS No. 1456509-46-8

Trimebutine CTB salt (GIC-1001) is an opioid receptor agonist used in the study of pain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 445 Get Quote
5MG 686 Get Quote
10MG 938 Get Quote
25MG 1398 Get Quote
50MG 1822 Get Quote
100MG 2403 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Trimebutine CTB salt
  • Note
    Research use only, not for human use.
  • Brief Description
    Trimebutine CTB salt (GIC-1001) is an opioid receptor agonist used in the study of pain.
  • Description
    Trimebutine CTB salt (GIC-1001) is an opioid receptor agonist used in the study of pain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    Opioid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1456509-46-8
  • Formula Weight
    604.74
  • Molecular Formula
    C29H36N2O8S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OCC(C=1C=CC=CC1)(N(C)C)CC)C2=CC(OC)=C(OC)C(OC)=C2.O=S(=O)(O)C=1C=CC=C(C1)C(=S)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • ADL-5747

    ADL-5747 (ADL-5747 (free base)) (free base) is a delta opioid receptor agonist used in the treatment of neurological disorders, skin and musculoskeletal disorders, and may be used in the study of postherpetic neuralgia, knee osteoarthritis and pain.

  • Apitegromab

    Apitegromab (SRK-015) is a new myostatin inhibitor, an antibody targeting myostatin precursor, which can be used to study neuromuscular diseases including spinal muscular atrophy.

  • Endomorphin 2?

    Endomorphins-2 (EM-2) could decrease both the frequency and amplitude of the sEPSC of the motoneurons in lamina IX which was reversed by the MOR antagonist CTOP.??